The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Advances Day 2019 | Challenges in myelofibrosis management
Andreas Reiter
• 15 Nov 2019
Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, shares his opinion on the most significant challenges in myelofibrosis management, including cytopenia, splenomegaly and related symptoms. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
